share_log

Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target

Benzinga ·  Nov 14 06:11  · Ratings

Chardan Capital analyst Geulah Livshits maintains Cargo Therapeutics (NASDAQ:CRGX) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment